跳至主要内容
临床试验/NCT02948660
NCT02948660已完成2 期

EEG Dynamics Induced by Zolpidem Forecasts Consciousness Evolution in Prolonged Disorders of Consciousness and Quantification of EEG Reactivity Predicts Recovery of Consciousness

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2017年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
The Coma Recovery Scale-Revised

研究概览

简要总结

The research contains two parts. Part 1: To explore whether EEG responses to zolpidem can assess consciousness circuit integrity and predict the evolution of consciousness in patients with prolonged disorders of consciousness; Part 2: To explore if quantitative EEG reactivity might predict the prognosis of disorders of consciousness.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of unresponsive wakefulness syndrome (UWS) or minimally conscious state (MCS) on admission;
  • time since onset > 4 weeks;
  • no history of neurodegenerative or psychiatric diseases.

排除标准

  • allergic to zolpidem;
  • currently receiving zolpidem or related benzodiazepines;
  • diagnosed with seizure or status epilepticus.

研究组 & 干预措施

Patients with prolonged disorders of consciousness

Experimental
  1. age ≥ 18 years;
  2. presence of unresponsive wakefulness syndrome (UWS) or minimally conscious state (MCS) on admission;
  3. time since onset > 4 weeks;
  4. no history of neurodegenerative or psychiatric diseases.

All patients were administered 10 mg of zolpidem tartrate tablets via a feeding tube and received EEG-reactivity test.

干预措施: Zolpidem Tartrate Tablets (Drug)

Healthy volunteers

Experimental

Healthy volunteers without any history of autonomic or any other nervous system disorder were included in this study. They were administered 10 mg of zolpidem tartrate tablets orally.

干预措施: Zolpidem Tartrate Tablets (Drug)

结局指标

主要结局

The Coma Recovery Scale-Revised

时间窗: Six months after enrollment

The consciousness was independently assessed using CRS-R six months after enrollment by a trained neurologist blinded to the clinical data. Patients who transitioned from UWS to MCS (UWS-MCS) or to emergence from MCS (EMCS) (UWS-EMCS), from MCS minus to MCS plus (MCS--MCS+) or to EMCS (MCS--EMCS), and from MCS to EMCS (MCS-EMCS) were categorized in the improved consciousness group. The unimproved consciousness was defined as a reduced or unchanged level of consciousness at six months.

次要结局

未报告次要终点

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验